ALISO VIEJO, Calif. , Oct. 21, 2024 /PRNewswire/ -- Okami Medical today announced the closing of a $32.
5M financing led by new investor Vensana Capital and joined by existing investors including U.S. Venture Partners, members of Okami's board of directors, and other medical device industry veterans.
Okami was launched by medical device incubator Inceptus Medical, whose principals previously founded other category-defining vascular companies including Inari Medical, Sequent Medical, and MicroVention. The financing provides Okami with capital to accelerate development and commercialization of its innovative catheter-based technologies for peripheral vascular occlusion. To-date, Okami has developed the LOBO ® Vascular Occlusion System and the SENDERO ® Microcatheter.
The LOBO Vascular Occlusion System is uniquely designed to provide interventional physicians with a single-device, one-and-done solution for the occlusion of a wide range of peripheral arterial targets without the need for multiple embolic devices. The SENDERO Microcatheter is designed for smooth delivery of interventional devices, while providing optimal trackability through tortuous peripheral vessels. "We are honored to have the support of Vensana and our existing investors to advance these important technologies and deliver them to patients," said Rhonda Robb , President and CEO of Okami.
"We are also grateful for the support and contributions of our employees and physician partners as we work tirelessly to bu.